The Centre for Future Health has to date appointed four outstanding early career fellows. Each has been awarded two years' worth of salary support plus a generous project spend budget. Their work ranges across three departments: Physics, Biology and History. Details of their careers to date and of their new projects are available below. We wish them every success.

A second cohort of fellows have now been recruited and details about them will appear here shortly.

Contact us

Centre for Future Health
CFH Project Officer
cfh@york.ac.uk
+44 (0)1904 328876
Research Centre for Social Sciences (room YH/202) University of York 6 Innovation Close Heslington York YO10 5ZF
@UoYFutureHealth

Dimitrios Kioumourtzoglou

Biography: Dimitrios studied at the University of Glasgow where he received his Bachelor of Science in 2008 and his PhD in Molecular and Cellular Biology in 2012. After a period at the University of Glasgow Dimitrios moved in 2014 to the University of York where he has been a research associate on a project aiming to improve the production of therapeutic monoclonal antibodies in mammalian cell lines.

Project: ‘Decoding insulin action: dissection of crosstalk between insulin-signalling and GLUT4-traffic’

Battling Type-2 Diabetes Mellitus (T2DM) represents one of the most major Global Health Care Challenges of the 21st century. In this debilitating disease tissues (mainly fat and muscle) that normally respond to insulin stop responding with the result that the cascade of cellular processes which clear excessive glucose from the bloodstream fail to initiate.

Many labs study the insulin-signalling pathways that occur at the start of this cascade, and many study the trafficking of a glucose transformer protein known as GLUT4 from internal stores in the cell to the cell surface (from where it enters the body’s circulation and goes on to facilitate the transport of excessive glucose into fat and muscle cells for storage) but little is known about the interface between these two processes and this is a major knowledge gap. Dimitrios will work with two internationally-recognised diabetes labs at the University of York (one in Biology, the other in Chemistry) that work respectively on insulin-signalling and GLUT4-trafficking and try to fill this knowledge gap by dissecting the signals in order to better understand how they mobilise GLUT4.

Adam Wollman

Biography: Adam completed his undergraduate Master of Physics degree at the University of York in 2009 and went on to pursue a DPhil in Condensed Matter Physics at the University of Oxford where he developed new hybrid protein-DNA nanotechnology, harnessing natural protein machines with DNA nanostructures. In 2013 he returned to York as a Postdoctoral Research Associate with Professor Mark Leake designing and building new single-molecule microscopes and analysis software. He has used these new tools in a variety of projects spanning nanotechnology, biology and health.

Project: ‘Nanosensors to understand glucose metabolism and disease, towards biomedical application’

Glucose fuels the human body and if not regulated correctly, as in diabetes, causes serious health problems. Over 400 million people have diabetes and it is now one of the leading causes of death worldwide. Adam’s research has tried to understand these basic mechanisms using yeast cells as a model organism and imaging them with a novel fluorescence microscope, which he designed and built, and is capable of imaging the individual protein molecules that sense and respond to glucose.

To better understand glucose metabolism, Adam proposes to develop a new glucose nanosensor which can enter the cell and measure, for the first time, the amount of glucose taken up by a living cell. This sensor technology could also have a more direct clinical application as the greater sensitivity would allow glucose monitoring from saliva, sweat or tears rather than the current more invasive blood sampling that is required.

José Juan-Colás

Biography: José studied at the Polytechnic University of Valencia where he received his MSc in Electrical and Electronic Engineering in 2013. He then moved to University of York to complete his PhD motivated by the opportunity to conduct original research and to collaborate with researchers not only in Electronics, but also in different disciplines (e.g. Chemistry and Biology). In 2016, after completing his inter-disciplinary PhD, he joined the Physics and Electronic Engineering departments as a research associate to develop a number of unique optical biosensing techniques that impact across health science, clinical practice and chemistry.
 
Project: Technologies to unravel the interaction pathways of bacterial communities
 
The excessive and often inappropriate use of antibiotics has led to the growing threat of antimicrobial resistance (AMR) which has been named as a “crisis for the health and wealth of nations”. Understanding the makeup and structure of bacterial communities and how bacteria interact with each other, when, and with the host is critical if we are to improve and reduce antibiotic usage and slow the spread of antibiotic resistance. This fellowship will support the development of new technology which aims to monitor communication and evolution in polymicrobial communities with high spatial and temporal resolution in conditions which precisely mimic those of the species’ natural environmental niche. Specifically the project will seek to develop a microfluidic co-culture system which provides complete control over local growth conditions, while providing non-invasive, multimodal measuring capabilities in situ.

Chris Ugbode

Biography: Following an undergraduate degree and masters by research at the University of Manchester, Christopher completed an industrial CASE PhD in Neuroscience working at both the University of Reading and Pfizer’s Neuroscience Research unit in Massachusetts. In 2015, he joined the University of York as a PDRA, modelling mutations that cause frontotemporal dementia (FTD) in mammalian cells.

Project: Understanding the role of glia in frontotemporal dementia

Frontotemporal dementia (FTD) is the second most common form of dementia after Alzheimer's Disease and causes a devastating early-onset dementia, striking between 45-65 years of age. FTD has a strong genetic link, with up to 50% of cases showing a family history. Whilst neuronal death is the major hallmark of neurodegenerative disease, the glial cells, during the disease process, completely change their function in a process called gliosis. I will study genetic mutations that induce FTD but in the context of glia. The aim is to understand how glia change during disease and whether these changes influence neuronal cell death. This work will identify glial specific drug targets to help prevent neurodegeneration in FTD.

Boyd Brogan

Biography: Boyd trained at Oxford as a literary historian, and held teaching posts there in early modern literature, before his work on the medical contexts of Milton’s drama Comus (1634) led him to interests in medical history that now form the core of his research. He has been a Wellcome-funded postdoctoral researcher at Cambridge since 2015, working on links between sexual abstinence and illness in early modern medicine and culture.

Project: ‘The Devil's Library: gender, convulsions and demonic possession in early modern and nineteenth-century medicine’

A key finding that has emerged from Boyd’s work at Cambridge has been the close historical relationship between epilepsy and hysteria. Where modern hysteria has been viewed as a psychological condition, in the sixteenth and seventeenth centuries it was seen as a physical illness whose key symptom, as in epilepsy, was convulsive seizures. Hysteria in this period was in fact sometimes known as ‘epilepsy from the womb’.

At York, Boyd’s project will follow this story into the present, by investigating the historical moment at which the modern separation between hysteria and epilepsy first became established, in work conducted in the 1870s and 1880s by the French neurologist Jean-Martin Charcot. In particular, his project will focus on Charcot’s Bibliotheque Diabolique (‘The Devil’s Library’). This was a series of new editions of early modern accounts of demonic possession, in which new footnotes and introductions explained how supposedly possessed persons were in reality merely suffering from hysteria. These works played a key role in publicising Charcot’s new hysteria concept, which strongly influenced the development of psychoanalysis and present-day diagnoses such as conversion disorder and PTSD.

Michael Bottery

Biography: Michael graduated from the University of Hull in 2010 and joined the University of York two years later where he completed a Masters by Research in 2013 and then a PhD in 2017. Most recently he has been working on a computational microbiology project in the University’s Centre for Immunology and Infection.

Project: Evaluating the invasion potential and diversification of Pseudomonas aeruginosa in response to the cystic fibrosis microbiome

Cystic fibrosis (CF) is a genetic disorder that leads to a build-up of sticky mucus in the lungs, allowing certain harmful bacteria to proliferate and establish persistent pulmonary infections. Pseudomonas aeruginosa is the most common of these bacteria and is the leading cause of death in CF. In order to establish an infection P. aeruginosa needs to effectively compete with the community of bacteria already present in the lung. This project will combine mathematical models with detailed microbiological experiments to test the hypothesis that a diversity of existing bacterial communities within the lung constrains the ability of P. aeruginosa to invade and become established due to niche overlap and competition. The project will also test how the nature of these communities alters the way the pathogen evolves during infection.

Katherine Bridge

Biography: Katherine completed a PhD at the University of Nottingham in 2013 and has most recently been working as a co-investigator on a BBSRC-funded project at Barts Cancer Institute, Queen Mary University of London.

Project: Characterisation and therapeutic targeting of novel regulators of HIF/hypoxia in myeloproliferative neoplasms

All organs and cells within our bodies require oxygen. Levels of oxygen within cells are regulated by a process called the hypoxic response. In cancer the hypoxic response is manipulated to help a cancerous cell grow beyond where and how it normally should, frequently causing cancers to become resistant to treatment and this is true for solid tumours and blood cancers alike. Myeloproliferative neoplasms (MPNs) are a type of blood cancer commonly caused by a mutation in a gene called JAK2. This project will investigate how this gene and the protein HIF (hypoxia inducible factor) which is responsible for coordinating the hypoxic response interact with the aim of identifying new treatment targets.

 

Alumni

Rebecca Wright

Rebecca has been appointed as a Lecturer in American History at Northumbria University. Before commencing her Fellowships at York she was a Research Fellow in Mass Observation Studies at the University of Sussex, where she is examining energy practices in the Mass Observation Archive. Between 2013-2016 she was a Research Fellow on the AHRC collaborative project, "Material Cultures of Energy" at Birkbeck College, where she worked on ‘Energy Futures’. She completed her PhD at Birkbeck College in 2015, and has held fellowships at the Library of Congress in Washington D.C., and the Huntington Library in California.

Project: ‘Powering Health: Energy and Wellbeing in the US and UK, 1900-1970’

Throughout the twentieth century energy systems and understandings of health and wellbeing have impacted on each other. Despite this interdependence, the history of energy remains a neglected subject within the medical humanities, and the history of medicine rarely features in histories of energy. By comparing the ways energy, health and wellbeing evolved in the US and the UK between 1900 and 1970 this project sought to address this disciplinary divide. The study asked how new models of health, hygiene and wellbeing impacted upon industry and upon governments’ attempts to manage demand across energy systems and national energy policies. It also asked how different energy sectors benefited from, and promoted, new health models to expand systems, build competitive advantage, and fix demand. The project examined a range of factors which shaped energy and health environments from the particularity of the energy mix to broader cultural, political and geographical considerations and in doing so strove to advance public and policy awareness of the intersections between energy, human health and the environment.

Andrew Gibson

Andrew has taken up a Junior Professorship at Ruhr University Bochum but is maintaining close ties with the University of York. He received his MSci degree in Physics and Medical Applications from Queen’s University Belfast in 2011 and his PhD in Physics from the same university in 2015. Since then he has undertaken post-doctoral roles at the University of York and Ecole Polytechnique, France. During this time, his work has focused on computational simulations and experimental diagnostics of low-temperature plasmas with respect to their applications in industry and biomedicine.

Project: ‘Accelerating low temperature plasmas towards clinical prostate cancer therapy through computer-aided design’

Due to their ability to produce a unique myriad of biologically active reactive oxygen and nitrogen species (RONS) low temperature plasmas (LTPs) have been proposed as a cancer therapy of the future. Poor treatment outcomes associated with current prostate cancer therapies make this cancer a prime target for such a novel approach. Through his Centre for Future Health Fellowship Andrew has been applying computational techniques from the field of plasma physics to study the biochemical interactions between low-temperature plasmas and prostate cancer cells. This approach will be used to overcome key challenges in understanding these complex systems and accelerate the development of low-temperature plasmas towards clinical applications in prostate cancer therapy.

Contact us

Centre for Future Health
CFH Project Officer
cfh@york.ac.uk
+44 (0)1904 328876
Research Centre for Social Sciences (room YH/202) University of York 6 Innovation Close Heslington York YO10 5ZF
@UoYFutureHealth